Literature DB >> 20641141

The efficiency frontier approach to economic evaluation: will it help German policy making?

Werner B F Brouwer1, Frans F H Rutten.   

Abstract

Mesh:

Year:  2010        PMID: 20641141     DOI: 10.1002/hec.1644

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


× No keyword cloud information.
  6 in total

1.  Presenting Germany's drug pricing rule as a cost-per-QALY rule.

Authors:  Afschin Gandjour
Journal:  Health Care Manag Sci       Date:  2011-12-21

Review 2.  Market access and value-based pricing of digital health applications in Germany.

Authors:  Daniel Gensorowsky; Julian Witte; Manuel Batram; Wolfgang Greiner
Journal:  Cost Eff Resour Alloc       Date:  2022-06-13

3.  Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG.

Authors:  Afschin Gandjour
Journal:  BMC Health Serv Res       Date:  2020-04-22       Impact factor: 2.655

4.  German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30.

Authors:  Georg Kemmler; Eva Gamper; Virginie Nerich; Richard Norman; Rosalie Viney; Bernhard Holzner; Madeleine King
Journal:  Qual Life Res       Date:  2019-09-04       Impact factor: 4.147

5.  Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makers.

Authors:  Björn Stollenwerk; Stefan K Lhachimi; Andrew Briggs; Elisabeth Fenwick; Jaime J Caro; Uwe Siebert; Marion Danner; Andreas Gerber-Grote
Journal:  Health Econ       Date:  2014-03-04       Impact factor: 3.046

6.  Cost-effectiveness of Interferon-free therapy for Hepatitis C in Germany--an application of the efficiency frontier approach.

Authors:  Christian Gissel; Georg Götz; Jörg Mahlich; Holger Repp
Journal:  BMC Infect Dis       Date:  2015-07-30       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.